166
Views
11
CrossRef citations to date
0
Altmetric
Review

Immunomodulatory drugs in chronic lymphocytic leukemia: A new treatment paradigm

, MD
Pages 866-869 | Received 15 Nov 2006, Accepted 16 Nov 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Iris Breitkreutz & Kenneth C Anderson. (2008) Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 973-985.
Read now

Articles from other publishers (10)

Katarzyna Skorka, Joanna Zaleska, Malgorzata Zajac, Agnieszka Karczmarczyk, Waldemar Tomczak, Paulina Wlasiuk, Malgorzata Kowal, Marlies Goetz, Jochen Greiner, Michael Schmitt & Krzysztof Giannopoulos. (2016) Indirect induction of regulatory T cells accompanies immune responses during peptide vaccination of chronic lymphocytic leukaemia patients. British Journal of Haematology 174:1, pages 155-157.
Crossref
Chava Perry, Inbal Hazan-Halevy, Sigi Kay, Michal Cipok, Dan Grisaru, Varda Deutsch, Aaron Polliack, Elizabeth Naparstek & Yair Herishanu. (2012) Increased CD39 expression on CD4+ T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia. Annals of Hematology 91:8, pages 1271-1279.
Crossref
Mohammed Shanshal & Rami Y. Haddad. (2012) Chronic Lymphocytic Leukemia. Disease-a-Month 58:4, pages 153-167.
Crossref
Shuo Ma & Steven T. Rosen. (2011) Signal transduction inhibitors in chronic lymphocytic leukemia. Current Opinion in Oncology 23:6, pages 601-608.
Crossref
Jason A. Dubovsky, Daniel Wang, John J. Powers, Emmanuel Berchmans, Matthew A. Smith, Kenneth L. Wright, Eduardo M. Sotomayor & Javier A. Pinilla-Ibarz. (2011) Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers. Leukemia Research 35:3, pages 394-404.
Crossref
Nicolas Dauguet, Jean-Jacques Fournié, Rémy Poupot & Mary Poupot. (2010) Lenalidomide down regulates the production of interferon-γ and the expression of inhibitory cytotoxic receptors of human Natural Killer cells. Cellular Immunology 264:2, pages 163-170.
Crossref
Monika Podhorecka, H. Dorota Halicka, Piotr Klimek, Malgorzata Kowal & Anna Dmoszynska. (2009) Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures. Leukemia Research 33:7, pages 997-1000.
Crossref
Jason A. Dubovsky, Douglas G. McNeel, John J. Powers, John Gordon, Eduardo M. Sotomayor & Javier A. Pinilla-Ibarz. (2009) Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen. Clinical Cancer Research 15:10, pages 3406-3415.
Crossref
Gondi Kumar, Henry Lau & Oscar Laskin. (2008) Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction. Cancer Chemotherapy and Pharmacology 63:6, pages 1171-1175.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.